ArticleAnalytical and bioanalytical chemistry2025

Development, validation, and clinical application of LC-MS/MS method for simultaneous determination of ibrutinib, zanubrutinib, orelabrutinib, acalabrutinib, and their active metabolites in patients with B-cell lymphoma.

Dan Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.